I don't like that the A/S was raised to a whopping 40 billion, but let's be honest, the company has no revenue other than selling shares so it is what it is. Pharma plays a lot of times have larger share structures on the OTC. However, if we ever hit that 40 billion mark it is all over here. Only thing to look forward to then will be a reverse split.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.